| WO/2005/089341 | METHOD AND DEVICE FOR CORONARY ARTERY BYPASS |
| WO/1998/039058 | EXTRACORPOREAL WHOLE BODY HYPERTHERMIA USING ALPHA-STAT REGULATION OF BLOOD pH AND pC0�2? |
| WO/2003/028797 | CUTANEOUS ADMINISTRATION SYSTEM |
OTTANELLI, Luciano (SIXTEM LIFE srl, via Adige 34, Sesto Fiorentino, I-50019, IT)
| CLAIMS 1. Device for dispensing one or more skin treatment substances, comprising a reservoir (2) for the treatment substances, a dispensing element (3) suited to dispense the substances onto the skin, a valve (4) suited to properly connect said reservoir (2) to said dispensing element (3), characterized in that said valve (4) comprises a dosage chamber (5) having a predetermined volume suited to contain one portion of the treatment substances, and substance passage means (6) suited to alternatively place said dosage chamber (5) in fluid communication with said reservoir (2) in order to fill it or with said dispensing element (3) in order to dispense the treatment substances. 2. Device according to claim 1, characterized in that said passage means (6) comprise a filling path (7) suited to fill said dosage chamber (5) and first closing means (9) suited to selectively obstruct said filling path (7) while the treatment substances are being dispensed. 3. Device according to claim 1, characterized in that said passage means (6) comprise an outlet path (8) suited to empty said dosage chamber (5) while the substances are being dispensed and second closing means (10) suited to selectively obstruct said outlet path (8) while said dosage chamber (5) is being filled. 4. Device according to one or more of the preceding claims, characterized in that said valve (4) comprises a stem (11) slidingly constrained along a longitudinal axis (L) between an extended position for filling said dosage chamber (5) and a retracted position for dispensing said treatment substances, and wherein the sliding movement of said stem (11) takes place through contact and pressure of the end of said stem (11) onto the surface to be treated. 5. Device according to claim 4, characterized in that said first closing means (9) comprise an external wall (12) of said stem (11) suited to come into selective contact with a corresponding elastic wall (13) of said dosage chamber (5) when said stem (11) is in said retracted position to obstruct said filling path (7)· 6. Device according to one or more of the preceding claims, characterized in that said valve (4) comprises a longitudinal hole (14) defining a sliding wall (15) suited to slidingly house said stem (11), said second closing means (10) comprising at least one transverse channel (16) created in said stem (11) and having a longitudinal position suited to allow it to be selectively obstructed by said sliding wall (15) when said stem (11) is in said extended position. 7. Device according to claim 6, characterized in that said dosage chamber (5) has a longitudinal end portion (17) in proximity to said dispensing element (3), said transverse channel (16) being positioned on said stem (11) in such a way as to be at the level of said longitudinal end portion (17) of said dosage chamber (5) when said stem (11) is in said retracted position. 8. Device according to claim 1, characterized in that said valve (4) comprises a longitudinal outlet duct (19), said dispensing element (3) comprising a longitudinal dispensing duct substantially aligned with said outlet duct (19). 9. Device according to claim 8, characterized in that said dispensing duct has an open longitudinal end (20) with a substantially plane edge (21) suited to be rested on the skin during the dispensing operation. 10. Device according to one or more of the preceding claims, characterized in that said dispensing element (3) comprises a side dispensing duct (22) arranged crosswise with respect to said longitudinal axis L, and a substantially curved internal path (23) suited to place said longitudinal outlet duct (19) in communication with said side dispensing duct (22). 11. Method for dispensing one or more skin treatment substances by means of a device carried out according to one or more of claims from 1 to 9, comprising the following stages: - said edge (22) of said dispensing element (3) is placed into contact with the skin in such a way as to delimit the area to be treated; - said longitudinal axis (L) is substantially aligned with the direction orthogonal to the skin at the level of the area to be treated and with the local vertical direction, said dispensing element (3) being directed downwards; - said dispensing element (3) is compressed in such a way as to make said stem (11) pass from said extended configuration to said retracted configuration in order to dispense the treatment substances. 12. Device according to any one of the preceding claims, characterized in that it is combined with a formula for the treatment of rhagades and small injuries, and its use can be extended to the cure and treatment of other skin diseases, said formula including eugenol and panthenol. 13. Device according to any one of the preceding claims, characterized in that it contains said formulation in spray solution for the treatment of rhagades and small injuries, suited to be transformed into a protective film against germs and bacteria, and suited to favour cicatrization and prevent rhagades-injuries from reappearing. |
D E S C R I P T I O N
Field of application of the invention
The present invention can be generally applied in the sector of surface topic treatments of skin pathologies and diseases and, in particular, it concerns a device for dispensing one or more substances for skin treatments of the type described in the preamble of claim 1, and a method for using said device.
State of the art
There are several examples of embodiment of devices for dispensing liquid and gaseous substances onto the skin, said substances being suitable for treating skin pathologies and diseases.
In particular, patent no. US5516505 describes a device for skin treatments comprising an elongated duct suited to convey a treatment fluid from the outlet valve of a pressurized container towards an applicator. The latter is made of a synthetic plastic foam. Patent EP0281212 describes an example of embodiment similar to the previous one, in which the fluid flows into a projection made of cotton wool, intended to come into contact with the skin surface to be treated. An evident drawback that is common to both these solutions lies in that the treatment fluid is dispensed onto the skin through direct contact between the skin and the applicator. According to this application method, the quantity of fluid that is applied to the skin and the skin area treated depend on several factors that are rather difficult to control, for example the contact pressure between the skin and the applicator and the deformability of the latter. As a consequence of the above, the treated area is often larger than the area affected by the disease or pathology, and the treatment fluid is spread on an area that does not require any treatment. Furthermore, the quantity of fluid conveyed may not be sufficient for the skin area actually affected by the disease, which goes to the detriment of the effectiveness of the treatment.
A further drawback that is common to the two solutions mentioned above lies in that during application the treatment fluid may easily drip on the skin, thus staining the clothes in proximity to the treatment area.
Patent no. GB1163573 describes a device suitable for the treatment of delimited skin areas. The device is provided with a tubular sleeve having an open longitudinal end and the other end connected to the outlet valve of a pressurized container. The edge of the open longitudinal end is intended to rest on the skin at the level of the area to be treated, in such a way as to confine the fluid only to the skin area delimited by the edge and to prevent the fluid from coming into contact with other areas of the skin.
A clear drawback posed by this last solution is represented by the fact that the quantity of treatment fluid that reaches the skin area delimited by the edge is not controlled and may be excessive or insufficient, depending on how long the outlet valve of the pressurized container remains open. In particular, if the quantity of fluid let out is excessive, once the edge of the open longitudinal end has been moved away from the skin after application, the excess fluid may spread in the surrounding areas, thus making it useless to confine the fluid with the edge of the open longitudinal end and making application potentially dangerous also in this case for the clothes near the area to be treated.
According to the state of the art, furthermore, there are many embodiments of devices for applying skin treatment fluids by spraying. In these solutions the fluid is atomized after coming out of a valve of a pressurized container. The atomized fluid is directed toward the skin in proximity to the area to be treated. A drawback posed by this solution lies in that the application area is generally much larger than necessary and cannot be easily and precisely circumscribed. A further drawback is represented by the fact that, also in this case, the quantity of fluid dispensed depends on how long the user keeps the valve open, thus considerably increasing the risk of making the treatment ineffective.
Description of the invention
A primary object of the invention is to eliminate the drawbacks mentioned above by means of a device for dispensing one or more skin treatment substances that is easy to use and at the same time highly effective against localized skin pathologies and diseases.
A particular object of the invention is to carry out a device capable of concentrating the treatment fluid only on the skin areas that actually need it. A further object of the invention is to propose a device that can dispense a predefined quantity of treatment substance onto the skin, thus guaranteeing easy and safe application and avoiding useless wastes.
Another specific object of the invention is to carry out a device capable of drastically reducing the risk of staining clothes in proximity to the skin area to be treated.
These objects, as well as others that will be highlighted in greater detail below, are achieved, according to claim 1, by a device for dispensing one or more skin treatment substances, comprising a reservoir suited to contain the treatment substances, an element for dispensing the substances onto the skin, a valve suited to properly connect said container to said dispensing element, and characterized in that said valve comprises a dosage chamber having a predetermined volume suited to contain one portion of the treatment substance, and substance passage means suited to alternately place said dosage chamber in fluid communication with said container in order to fill it or with said dispensing element in order to dispense the treatment substances.
Thanks to this particular configuration it will be possible to properly dispense the correct portion of treatment substance onto the skin and to maximize the effectiveness of the treatment.
The device described above can be specifically used in combination with an innovative formula, focusing in particular on the treatment of rhagades and small injuries, and extending use to the cure and treatment of other skin diseases.
Products are known which are used in relation to rhagades and are described here below in order to better explain the innovative idea proposed by the invention compared to pre-existing products available on the market.
There are hydrocolloid plasters shaped like a half moon which are suited to cover rhagades on the fingers of the hand and the nail contour. Said plasters are difficult to apply and they don't stick for long.
Plasters and treatments in liquid solution are also known, which are applied in a traditional way by means of a brush or spatula that is used repeatedly to apply all the doses contained in the package. The above mentioned spatula is internally connected to the container closing cap, and after use it is stored inside said cap and remains in contact with the product.
Spray plasters are also known, which are applied through a continuous valve and allow application in undetermined quantities.
The invention described herein, in spray solution for the treatment of rhagades and small injuries, comprises a combination of said device and a medicament, with advanced formulation in a spray solution, practical and effective, suited to be transformed into a protective film against germs and bacteria, which thanks to its special formula favours cicatrization and prevents rhagades-injuries from reappearing. The device with predetermined dosage makes it possible to use the product in the correct pre-established quantity, that is, the quantity that is necessary and sufficient to treat rhagades and small injuries, avoiding useless product wastes.
The device is structured in such a way as to be activated with overturned bottle, to facilitate dispensing and avoid spraying the product into the eyes, thus ensuring safer and more appropriate use.
The new dispensing system allows the product to be applied through the air, with a direct liquid jet, avoiding the use of further accessories (brush-spatula, etc.). Therefore, the device also ensures more hygiene during use and therefore can also be used interpersonally (for example, within the same family).
The device is provided with a suitable cap, to be used to cover the applicator nozzle, in order to hygienically protect the device after use.
The advanced formulation medicament contained in the bottle is suitable for treating rhagades and small injuries and contains eugenol and panthenol.
Eugenol (C 10 H 10 O 2 ) is an hydroxilated aromatic compound belonging to the chemical class of allylbenzenes. It is an oily liquid, almost transparent or light yellow in colour, which is extracted from some essential oils, in particular from clove oil and cinnamon. It is hardly soluble in water and soluble in organic solvents, has a pleasant colour and is spicy, similar to clove. Eugenol also has disinfecting properties and light local anaesthetic and anti-inflammatory properties.
Panthenol is an active principle widely used in cosmesis for its hydrating and soothing action. Technically speaking, it is provitamin B5, the substance that must be transformed into vitamin by the organism before being used, and has good anti-inflammatory properties; it serves its function by intensifying lipid synthesis and promoting proliferation of fibroblasts.
Brief description of the drawings
The characteristics of the new dispensing device will be highlighted in greater detail in the following description, with reference to the drawings attached as non-limiting examples.
Figure 1 shows an overall exploded view of the device;
Figure 2 shows a section view of the valve in retracted position;
Figure 3 shows a section view of the valve in extended position;
Figure 4 shows a section view of the dispensing element with side dispensing duct.
Detailed description of a preferred embodiment of the invention
The device is described with particular reference to the enclosed figures, the reference numbers used in the description and in the claims are used to improve the intelligibility of the invention and do not constitute a limitation to the claimed scope of protection.
The device carried out according to the invention for dispensing one or more skin treatment substances is indicated as a whole by reference number 1. The treatment substances can be gaseous or liquid, or a mixture of gaseous and/or liquid and/or solid components. The device 1 comprises a reservoir 2 suited to contain the treatment substances, a dispensing element 3 suited to apply the substances to the skin, and a valve 4 capable of properly connecting the reservoir 2 to the dispensing element 3 (Figure 1). A cap 3' can also be provided to cover and protect the dispensing element 3.
A particular characteristic of the invention lies in that the valve 4 comprises a dosage chamber 5 having a predetermined volume, such that it contains an optimal quantity of the treatment substances. The valve 4 also comprises passage means 6 suited to allow the tratment substances to pass from the reservoir 2 to the dosage chamber 5 while the latter is being filled, or alternatively from the dosage chamber 5 to the dispensing element 3 while the treatment substances are dispensed onto the skin.
In greater detail, the passage means 6 may comprise a filling path 7 (Figure 3) designed to be active during the filling of the dosage chamber 5 and an outlet path 8 (Figure 2) designed to empty the dosage chamber 5 while the substances are being dispensed. Preferably, the filling path 7 and the outlet path 8 are never active at the same time, which prevents uncontrolled passage of the treatment substances directly from the reservoir 2 to the dispensing element 3. This particular behaviour can be obtained through first closing means 9 capable of selectively obstructing the filling path 7 while the treatment substances are being dispensed, and through second closing means 10 capable of selectively obstructing the outlet path 8 while the dosage chamber 5 is being filled.
The valve 4 may comprise a stem 11 constrained to the main body of the valve 4 so as to slide along a longitudinal axis L. The stem 11 can move between an extended position (Figure 3) during the filling of the dosage chamber 5 and a retracted position (Figure 2) during application of the treatment substances to the skin.
The first closing means 9 may comprise an external wall 12 of the stem 11 and an elastic wall 13 of the dosage chamber 5, which can come into contact when the stem 11 is in retracted position. Said contact can take place only during the dispensing stage and makes it possible to obstruct the filling path 7, thus preventing the substances present in the reservoir 2 from entering the dosage chamber 5 and flowing onto the skin in an uncontrolled manner. In greater detail, in a particular example of embodiment the stem 11 can slide inside a longitudinal hole 14 provided in the valve 4. The inner wall of the longitudinal hole 14 forms a sliding wall 15 for the stem 11. Furthermore, the second closing means 10 may comprise at least one transverse channel 16 created in the stem 11. Said transverse channel 16 is positioned on the stem 11 in a longitudinal position that is such as to allow the channel to be obstructed by the sliding wall 15 when the stem 11 is in extended position. In this way, during the filling of the dosage chamber 5, the treatment substances cannot pass through the transverse channel 16 and cannot flow out through the dispensing element 3. On the contrary, when the stem 11 is in retracted position (Figure 2), the transverse channel 16 places the dosage chamber 5 in communication with the dispensing element, thus allowing the treatment substances to flow out.
As shown in Figure 3, the dosage chamber 5 may have a longitudinal end portion 17 nearer to the dispensing element 3 and a portion 18 nearer to the reservoir, situated on the opposite side along the longitudinal axis L. A further special characteristic of the invention lies in that the transverse channel 16 can be positioned on the stem 11 in such a way as to be at the level of the longitudinal end portion 17 of the dosage chamber 5 when the stem 11 is in retracted position. This features allows the device of the invention to be advantageously used with the dispensing element 3 directed downwards, ensuring substantially complete emptying of the dosage chamber 5.
The outlet path 8 may comprise a longitudinal outlet duct 19, and the dispensing element 3 may comprise a longitudinal dispensing duct substantially aligned with the outlet duct 19. This detail favours the rapid and complete discharge of the substance from the dosage chamber 5 during the dispensing stage.
According to a preferred embodiment of the invention, the longitudinal dispensing duct of the dispensing element 3 may have an open longitudinal end 20 with a substantially plane edge 21 suited to be rested on the skin during the dispensing stage. This configuration makes it possible to confine the treatment substances inside the area defined by the edge 21. Furthermore, the combination of a precise dosage, obtained through the dosage chamber 5, with a defined application area makes it possible to apply an optimal quantity of substances, thus obtaining a correct thickness of the substance layer applied to the skin.
According to an alternative embodiment of the device of the invention, the dispensing element 3 may comprise a side dispensing duct 22 arranged crosswise with respect to the longitudinal axis L, in such a way as to ensure that the treatment substances can be comfortably applied to the skin even when the available space is limited (Figure 4). The dispensing element 3 may also comprise a substantially curved internal path 23 suited to place the longitudinal outlet duct 19 in communication with the side dispensing duct 22, thus allowing the passage of the treatment substances. Also in this embodiment a cap 24 can be provided, suited to selectively close the side dispensing duct 22. A method for using the device of the invention is described here below. The method for dispensing one or more skin treatment substances comprises the following stages:
a) the edge 21 of the dispensing element 3 is placed into contact with the skin in such a way as to delimit the area to be treated;
b) to ensure optimal dispensing of mixtures of gaseous, liquid and solid substances, the longitudinal axis L can be substantially aligned with the direction orthogonal to the skin at the height of the surface to be treated, and with the local vertical direction. Furthermore, the dispensing element 3 can be directed downwards, in such a way as to guarantee the optimal emptying of the dosage chamber 5;
c) the dispensing element 3 can be pressed against the valve 4 in such a way as to make the stem 11 pass from the extended configuration to the retracted configuration to dispense the treatment substances.
The above clearly shows that the device carried out according to the invention achieves the set objects and in particular allows a pre-established quantity of treatment substances to be dispensed onto a delimited skin area, thus guaranteeing high effectiveness of the treatment.
Therefore, with reference to the preceding description, the following claims are expressed.